Resultados da pesquisa - brain tumors ((((ras treat) OR (gps treat))) or (a treat))

Pesquisas alternativas:
ras treat » res treat (Expandir a Pesquisa), ras tert (Expandir a Pesquisa), vs treat (Expandir a Pesquisa)
a treat » _ treat (Expandir a Pesquisa), a treated (Expandir a Pesquisa)

1

Oncogenic KRAS promotes malignant brain tumors in zebrafish

Oncogenic KRAS promotes malignant brain tumors in zebrafish

Por Ju, Bensheng, Chen, Wenbiao, Orr, Brent A, Spitsbergen, Jan M, Jia, Sujuan, Eden, Christopher J, Henson, Hannah E, Taylor, Michael R
Publicado no Mol Cancer (2015)

“... devastating and difficult to treat. In this study, we evaluated zebrafish as a brain tumor model...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

2

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling

Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling

Por Cockle, Julia V., Rajani, Karishma, Zaidi, Shane, Kottke, Timothy, Thompson, Jill, Diaz, Rosa Maria, Shim, Kevin, Peterson, Tim, Parney, Ian F., Short, Susan, Selby, Peter, Ilett, Elizabeth, Melcher, Alan, Vile, Richard
Publicado no Neuro Oncol (2016)

“... stomatitis virus (VSV) treats tumors by vaccinating against a wide range of tumor associated antigens (TAAs...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

3

Organotypic brain explant culture as a drug evaluation system for malignant brain tumors

Organotypic brain explant culture as a drug evaluation system for malignant brain tumors

Por Minami, Noriaki, Maeda, Yusuke, Shibao, Shunsuke, Arima, Yoshimi, Ohka, Fumiharu, Kondo, Yutaka, Maruyama, Koji, Kusuhara, Masatoshi, Sasayama, Takashi, Kohmura, Eiji, Saya, Hideyuki, Sampetrean, Oltea
Publicado no Cancer Med (2017)

“... based on expression of H‐Ras(V12) in Ink4a/Arf (−/−) neural stem/progenitor cells to establish tumor...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

4

Demonstration of differential radiosensitivity based upon mutation profile in metastatic melanoma treated with stereotactic radiosurgery

Por Rutter, Charles E., Johung, Kimberly L., Yao, Xiaopan, Lu, Alex Y., Jilaveanu, Lucia B., Yu, James B., Contessa, Joseph N., Kluger, Harriet M., Chiang, Veronica L.S., Bindra, Ranjit S.
Publicado no J Radiosurg SBRT (2016)

“... with metastatic melanoma were identified in a prospective stereotactic radiosurgery (SRS) database. Tumor were...”
Obter o texto integral
Obter o texto integral

Artigo

5

Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells

Suppression of RAF/MEK or PI3K synergizes cytotoxicity of receptor tyrosine kinase inhibitors in glioma tumor-initiating cells

Por Shingu, Takashi, Holmes, Lindsay, Henry, Verlene, Wang, Qianghu, Latha, Khatri, Gururaj, Anupama E., Gibson, Laura A., Doucette, Tiffany, Lang, Frederick F., Rao, Ganesh, Yuan, Liang, Sulman, Erik P., Farrell, Nicholas P., Priebe, Waldemar, Hess, Kenneth R., Wang, Yaoqi A., Hu, Jian, Bögler, Oliver
Publicado no J Transl Med (2016)

“... to improve survival of nude mice bearing GSC11 brain tumor. Reverse phase protein array analysis...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

6

Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel

Por Ngo, Mai T., Harley, Brendan A.C.
Publicado no Biomaterials (2018)

“...Glioblastoma (GBM) is the most common primary malignant brain tumor, with patients exhibiting poor...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

7

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis

Pazopanib reveals a role for tumor cell B-Raf in the prevention of HER2+ breast cancer brain metastasis

Por Gril, Brunilde, Palmieri, Diane, Qian, Yong, Smart, DeeDee, Ileva, Lilia, Liewehr, David J., Steinberg, Seth M., Steeg, Patricia S.
Publicado em 2010

“... and treated with vehicle or pazopanib beginning on day 3 post-injection. Brain metastases were counted...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

8

LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

LGG-08. A PHASE II PROSPECTIVE STUDY OF SELUMETINIB IN CHILDREN WITH RECURRENT OR REFRACTORY LOW-GRADE GLIOMA (LGG): A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY

Por Fangusaro, Jason, Onar-Thomas, Arzu, Poussaint, Tina Y, Wu, Shengjie, Ligon, Azra H, Lindeman, Neal, Banerjee, Anu, Packer, Roger J, Kilburn, Lindsay B, Pollack, Ian F, Jakacki, Regina I, Qaddoumi, Ibrahim, Fisher, Paul G, Dhall, Girish, Baxter, Patricia, Kreissman, Susan G, Stewart, Clinton F, Pfister, Stefan M, Jones, David TW, Vezina, Gilbert, Stern, Jessica, Panigrahy, Ashok, Jones, Blaise V, Patay, Zoltan, Tamrazi, Benita, Jones, Jeremy Y, Haque, Sofia S, Enterline, David S, Cha, Soonmee, Doyle, Laurence A, Smith, Malcolm, Boyett, James M, Dunkel, Ira J, Fouladi, Maryam
Publicado no Neuro Oncol (2017)

“...A greater understanding of the Ras-MAP kinase-signaling pathway in pediatric low-grade glioma (LGG...”
Obter o texto integral
Obter o texto integral

Artigo

9

CMET-19. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR GROWTH FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES

CMET-19. CLINICAL RISK ASSESSMENT SCORE TO ESTIMATE THE LIKELIHOOD OF PSEUDOPROGRESSION VERSUS TUMOR GROWTH FOLLOWING STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASES

Por Skeie, Bente, Øyvind Enger, Per, Pedersen, Paal-Henning, Olve Skeie, Geir
Publicado no Neuro Oncol (2018)

“...A major challenge in the follow-up of patients managed with stereotactic radiosurgery (SRS) brain...”
Obter o texto integral
Obter o texto integral

Artigo

10

Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma

Recombinant Interleukin-1 Receptor Antagonist Conjugated to Superparamagnetic Iron Oxide Nanoparticles for Theranostic Targeting of Experimental Glioblastoma

Por Maxim A. Shevtsov, Boris P. Nikolaev, Ludmila Y. Yakovleva, Anatolii V. Dobrodumov, Alexander V. Zhakhov, Anastasiy L. Mikhrina, Emil Pitkin, Marina A. Parr, Valerii I. Rolich, Andrei S. Simbircev, Alexander M. Ischenko
Publicado em 2015-01-01

“...Cerebral edema commonly accompanies brain tumors and contributes to neurologic symptoms. The role...”
Obter o texto integral

Artigo

11

The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site

Por Alonso-Camino, Vanesa, Rajani, Karishma, Kottke, Timothy, Rommelfanger-Konkol, Diana, Zaidi, Shane, Thompson, Jill, Pulido, Jose, Ilett, Elizabeth, Donnelly, Oliver, Selby, Peter, Pandha, Hardev, Melcher, Alan, Harrington, Kevin, Diaz, Rosa Maria, Vile, Richard
Publicado no Mol Ther (2014)

“... brain tumors. The optimal combination of antigens identified from the ASMEL which treated s.c. B16...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

12

TMOD-43. A PORCINE MODEL OF NEUROFIBROMATOSIS TYPE I-ASSOCIATED NERVOUS SYSTEM TUMORS

TMOD-43. A PORCINE MODEL OF NEUROFIBROMATOSIS TYPE I-ASSOCIATED NERVOUS SYSTEM TUMORS

Por Isakson, Sara, Coutts, Alex, Largaespada, David, Watson, Adrienne
Publicado no Neuro Oncol (2017)

“...Neurofibromatosis Type I (NF1) is a common autosomal dominant cancer predisposition syndrome...”
Obter o texto integral
Obter o texto integral

Artigo

13

DIPG-11. ACTIVATION OF RAS SIGNALING AND DISTINCT MITOGEN-ACTIVATED PROTEIN KINASES (MAPKs) PROVIDES UNIQUE THERAPEUTIC VULNERABILITIES IN MUTANT HISTONE DIPG

DIPG-11. ACTIVATION OF RAS SIGNALING AND DISTINCT MITOGEN-ACTIVATED PROTEIN KINASES (MAPKs) PROVIDES UNIQUE THERAPEUTIC VULNERABILITIES IN MUTANT HISTONE DIPG

Por Koncar, Robert, Stanton, Ann-Catherine, Dey, Brittany, Agrawal, Nishant, Wassell, Michelle, McCarl, Lauren, Locke, Abigail, Sanders, Lauren, Vaske, Olena Morozova, Kohanbash, Gary, Felker, James, James, C David, Hashizume, Rintaro, Broniscer, Alberto, Pollack, Ian, Agnihotri, Sameer
Publicado no Neuro Oncol (2019)

“...Diffuse intrinsic pontine gliomas (DIPGs) are incurable pediatric brain tumors with an aggressive...”
Obter o texto integral
Obter o texto integral

Artigo

14

DIPG-22. GENETIC MODELING IMPLICATES RAS AND MYC AS KEY EPIGENETICALLY ACTIVATED TRANSCRIPTIONAL TARGETS OF H3K27M-DRIVEN CANCER

DIPG-22. GENETIC MODELING IMPLICATES RAS AND MYC AS KEY EPIGENETICALLY ACTIVATED TRANSCRIPTIONAL TARGETS OF H3K27M-DRIVEN CANCER

Por Siddaway, Robert, Pajovic, Sanja, Kim, Byungjin, Ryall, Scott, Agnihotri, Sameer, Li, Christopher, Hawkins, Cynthia
Publicado no Neuro Oncol (2019)

“... to primary high-grade gliomas. The tumors had a cell-type independent expression signature featuring RAS...”
Obter o texto integral
Obter o texto integral

Artigo

15

Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review

Long-lasting stable disease with mTOR inhibitor treatment in a patient with a perivascular epithelioid cell tumor: A case report and literature review

Por Flechter, Ezequiel, Zohar, Yaniv, Guralnik, Ludmila, Passhak, Maria, Sela, Gil Bar
Publicado no Oncol Lett (2016)

“... that metastasized to the brain and lungs. Following resection of the brain metastasis, the patient was treated...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

16

Pediatric low-grade glioma in the era of molecular diagnostics

Pediatric low-grade glioma in the era of molecular diagnostics

Por Scott Ryall, Uri Tabori, Cynthia Hawkins
Publicado em 2020-03-01

Assuntos: “...brain tumor...”
Obter o texto integral

Artigo

17

RARE-31. DUAL BRAF/MEK THERAPY FOR PATIENTS WITH BRAF V600E-MUTATED TUMORS: DRAMATIC CLINICAL AND RADIOGRAPHIC RESPONSES AND A REDUCTION IN CUTANEOUS TOXICITY

RARE-31. DUAL BRAF/MEK THERAPY FOR PATIENTS WITH BRAF V600E-MUTATED TUMORS: DRAMATIC CLINICAL AND RADIOGRAPHIC RESPONSES AND A REDUCTION IN CUTANEOUS TOXICITY

Por Bernstein, Aaron, Mrowczynski, Oliver, Khalsa, Amrit, Ryan, Sandra, Chung, Catherine, Glantz, Michael
Publicado no Neuro Oncol (2017)

“... brain tumors including pleomorphic xanthoastrocytoma (66%), pilocytic astrocytoma (9%), primary...”
Obter o texto integral
Obter o texto integral

Artigo

18

Adherence to Antiemetic Guidelines in Patients with Malignant Glioma: A Quality Improvement Project to Translate Evidence into Practice

Adherence to Antiemetic Guidelines in Patients with Malignant Glioma: A Quality Improvement Project to Translate Evidence into Practice

Por Affronti, Mary Lou, Schneider, Susan M., Herndon, James E., Schlundt, Susan, Friedman, Henry S.
Publicado no Support Care Cancer (2014)

“... impair cancer patients’ quality of life (QOL). Review of Duke University Preston Robert Tisch Brain Tumor...”
Obter o texto integral
Obter o texto integral
Obter o texto integral

Artigo

19

TMOD-17. A NOVEL ADENOVIRAL-PERMISSIVE, IMMUNOCOMPETENT HAMSTER MODEL TO EVALUATE ONCOLYTIC ADENOVIRAL THERAPY FOR GLIOBLASTOMA

TMOD-17. A NOVEL ADENOVIRAL-PERMISSIVE, IMMUNOCOMPETENT HAMSTER MODEL TO EVALUATE ONCOLYTIC ADENOVIRAL THERAPY FOR GLIOBLASTOMA

Por Phillips, Lynette, Li, Shoudong, Gumin, Joy, Ledbetter, Daniel, Hossain, Anwar, Kerrigan, Brittany, Gomez-Manzano, Candelaria, Fueyo, Juan, Lang, Frederick
Publicado no Neuro Oncol (2018)

“... and viral-mediated anti-tumor immune response. However, it is unclear why only a fraction of patients...”
Obter o texto integral
Obter o texto integral

Artigo

20

37.3 INVOLVEMENT OF ANGIOTENSIN II TYPE 1 RECEPTOR (AT1R) IN SCHIZOPHRENIA: A NEW TARGET FOR DRUG REPURPOSING

37.3 INVOLVEMENT OF ANGIOTENSIN II TYPE 1 RECEPTOR (AT1R) IN SCHIZOPHRENIA: A NEW TARGET FOR DRUG REPURPOSING

Por Lucena, David F, Vasconcelos, Germana, De Lucena, David
Publicado no Schizophr Bull (2019)

“... polymorphism and susceptibility to schizophrenia were demonstrated. Brain renin-angiotensin system (RAS...”
Obter o texto integral
Obter o texto integral

Artigo